Home › Peripheral Arterial Disease › South Carolina
Pag-aaral pangklinika para sa Peripheral Arterial Disease sa South Carolina
7 pag-aaral para sa Peripheral Arterial Disease ang naghahanap ng mga kalahok sa mga site sa South Carolina.
Mga Lungsod sa South Carolina
Opisyal na teksto ng pag-aaral (English)
EVERO Drug-coated Balloon (DCB) Randomized Trial
- Prisma Health Memorial, Greenville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07144150Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Columbia Nephrology, Columbia
- CN Clinical Research LLC, Greenville
- Dialysis Clinic, Inc., Spartanburg
- at 1 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Spartanburg Regional Medical Center, Spartanburg
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06321575Serranator POINT FORCE Registry
- Prisma Health, Greenville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT06687590Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
- Prisma Heath-University Medical Group, Greenville
Nagre-recruitPhase 4
Lahat ng edad · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT06777901Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
- Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT02915198Pounce™ Thrombectomy System Retrospective Registry
- Prisma Health Upstate, Greenville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2025 · NCT05868161Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.